Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
iShares Global Healthcare ETF
IXJ
$4.51B
| $21.4M | 0.01% |
393,402
+15,162
| +4% | +$834K |
2013 Q2
8 quarters
|
|
1427
Royal Gold
RGLD
$20.1B
| $21.4M | 0.01% |
347,028
+130,587
| +60% | +$8.37M |
2013 Q2
8 quarters
|
|
1428
ProShares Investment Grade-Interest Rate Hedged
IGHG
$393M
| $21.3M | 0.01% |
278,642
+51,598
| +23% | +$3.98M |
2014 Q4
2 quarters
|
|
|
FPL
1429
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
| $21.3M | 0.01% |
1,356,389
+29,832
| +2% | +$506K |
2014 Q2
4 quarters
|
|
1430
The Greenbrier Companies
GBX
$1.21B
| $21.3M | 0.01% |
453,807
+220,323
| +94% | +$13.1M |
2013 Q2
8 quarters
|
|
1431
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.86B
| $21.3M | 0.01% |
2,355,950
-208,800
| -8% | -$1.95M |
2013 Q2
8 quarters
|
|
|
STRZA
1432
DELISTED
Starz - Series A
STRZA
| $21.2M | 0.01% |
474,618
+192,912
| +68% | +$7.68M |
2013 Q2
8 quarters
|
|
1433
AllianceBernstein Global High Income Fund
AWF
$827M
| $21.2M | 0.01% |
1,764,385
-21,142
| -1% | -$261K |
2013 Q2
8 quarters
|
|
1434
Brunswick
BC
$4.18B
| $21.2M | 0.01% |
416,861
+87,046
| +26% | +$4.55M |
2013 Q2
8 quarters
|
|
1435
Invesco S&P Global Water Index ETF
CGW
$1.04B
| $21.1M | 0.01% |
739,688
-85,259
| -10% | -$2.5M |
2013 Q2
8 quarters
|
|
1436
Aecom
ACM
$7.57B
| $21.1M | 0.01% |
639,012
+489,497
| +327% | +$16.2M |
2013 Q2
8 quarters
|
|
1437
iShares MSCI Italy ETF
EWI
$1.14B
| $21M | 0.01% |
706,732
+362,114
| +105% | +$11.2M |
2013 Q2
8 quarters
|
|
1438
Prospect Capital
PSEC
$843M
| $21M | 0.01% |
2,854,327
+397,724
| +16% | +$3.19M |
2013 Q2
8 quarters
|
|
1439
Vanguard Communication Services ETF
VOX
$5.95B
| $21M | 0.01% |
241,739
-84,298
| -26% | -$7.45M |
2013 Q2
8 quarters
|
|
1440
Thomson Reuters
TRI
$47B
| $21M | 0.01% |
475,358
+151,789
| +47% | +$7.11M |
2013 Q2
8 quarters
|
|
1441
Fresenius Medical Care
FMS
$11.8B
| $21M | 0.01% |
504,590
+93,440
| +23% | +$3.99M |
2013 Q2
8 quarters
|
|
|
TMX
1442
DELISTED
Terminix Global Holdings, Inc.
TMX
| $21M | 0.01% |
866,046
+733,084
| +551% | +$17M |
2014 Q3
3 quarters
|
|
|
ELNK
1443
DELISTED
EarthLink Holdings Corp.
ELNK
| $20.9M | 0.01% |
2,791,449
+1,990,022
| +248% | +$12.1M |
2013 Q2
8 quarters
|
|
1444
DELISTED
Time Inc.
TIME
| $20.9M | 0.01% |
908,066
-33,767
| -4% | -$771K |
2014 Q2
4 quarters
|
|
1445
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.18B
| $20.9M | 0.01% |
638,060
-67,369
| -10% | -$2.34M |
2013 Q2
8 quarters
|
|
1446
Blackstone Strategic Credit 2027 Term Fund
BGB
$494M
| $20.9M | 0.01% |
1,335,413
+105,342
| +9% | +$1.71M |
2013 Q2
8 quarters
|
|
1447
Calamos Convertible and High Income Fund
CHY
$896M
| $20.8M | 0.01% |
1,568,288
+50,909
| +3% | +$725K |
2013 Q2
8 quarters
|
|
|
CST
1448
DELISTED
CST Brands, Inc.
CST
| $20.8M | 0.01% |
532,700
-486,227
| -48% | -$20.2M |
2013 Q2
8 quarters
|
|
1449
Regal Rexnord
RRX
$10.2B
| $20.8M | 0.01% |
285,851
+62,342
| +28% | +$4.82M |
2013 Q2
8 quarters
|
|
|
BSJI
1450
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $20.7M | 0.01% |
799,538
+92,041
| +13% | +$2.4M |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.